P. Richart

SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)

M. Alsina, F. Rivera, P. Jiménez-Fonseca, 2020, Clinical and Translational Oncology.

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

J. Aparicio, J. Maurel, J. Capdevila, 2022, Clinical and Translational Oncology.

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma

N. Tarazona, S. Roselló, M. Huerta, 2022, British Journal of Cancer.

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience

J. Aparicio, J. García, A. Segura, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Hodgkin lymphoma in older patients

J. García, Helena de la Cueva, R. Díaz, 2009 .

SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)

F. Rivera, A. Férnández-Montes, C. Gómez-Martín, 2022, Clinical and Translational Oncology.